DEF 14C: Trustfeed Corp. Plans Name Change, Reverse Stock Split, and Incentive Plan Following Merger Agreement

Trustfeed Corp. announces plans for a name change to Polomar Health Services, Inc., a reverse stock split, and the adoption of a new equity incentive plan, following a merger agreement with Polomar Specialty Pharmacy, LLC.

Summary

• Trustfeed Corp. is informing stockholders about corporate actions approved on July 11, 2024, by a holder representing 84.3% of voting stock and the board of directors.
• These actions include changing the company name to Polomar Health Services, Inc., increasing authorized preferred stock to 5,000,000 shares, and potentially implementing a 1-for-10 reverse stock split.
• The company is also adopting a 2024 Equity and Incentive Compensation Plan.
• These actions are related to a merger agreement with Polomar Specialty Pharmacy, LLC, where Trustfeed's subsidiary will merge with Polomar, and former Polomar members are expected to own 75% of the company.
• The majority owner, CWR 1, LLC, will convert its Series A Preferred Stock and return common stock to ensure a public float of at least 10% after the merger.
• The company has also entered into a license agreement with Pinata Holdings, Inc. for intellectual property rights related to drug delivery.
• The name change and reverse stock split require notification to FINRA at least 10 days before the record date.
• The actions will not be effective until at least 20 calendar days after mailing the information statement to stockholders.
• The 2024 Equity and Incentive Compensation Plan reserves 5,000,000 shares for issuance, subject to adjustments and an annual increase.

Sentiment

Score: 6

Explanation: The document presents a mix of positive and negative aspects. The merger and incentive plan are positive, but potential dilution and takeover risks temper the outlook.

Positives

• The name change to Polomar Health Services, Inc. is expected to aid in achieving brand recognition and better position the company to obtain future financing.
• The reverse stock split is intended to make the company more attractive to potential merger candidates, employees, and investors.
• The 2024 Equity and Incentive Compensation Plan is designed to attract, motivate, and retain experienced and highly qualified individuals.
• The merger with Polomar Specialty Pharmacy, LLC is expected to create value for the company and its stockholders.
• The license agreement with Pinata Holdings, Inc. provides access to intellectual property rights for proprietary drug delivery.

Negatives

• The issuance of authorized but unissued stock could be used to deter a potential takeover of the company.
• Future issuances of common stock and/or preferred stock may have a dilutive effect on the earnings per share, voting power, and other interests of the existing stockholders.
• The effect of a reverse stock split on the market price of the common stock cannot be predicted with any certainty.
• The company currently has no funds available to pay officers or directors.

Risks

• The merger may not be completed, even though the company has incurred costs and expenses related to it.
• The market price of the common stock may vary based on factors unrelated to the number of shares outstanding.
• The company's sole officer and directors have not received any compensation for services rendered to the company.
• The company may not be able to successfully integrate Polomar Specialty Pharmacy, LLC after the merger.
• The company may not be able to successfully commercialize the intellectual property rights licensed from Pinata Holdings, Inc.

Future Outlook

The company anticipates raising additional capital from the sale of shares of its Preferred Stock in the future, although there is no assurance that this will occur.

Management Comments

• We wish to move away from the Trustfeed brand as we move into other business opportunities.
• We believe that changing our name to Polomar Health Services, Inc. is more in line with our expected line of business even if the Merger is not consummated, and the potential beneficial effects of the name change are expected to aid us in achieving brand recognition and better position us to obtain future sources of financing.

Industry Context

The announcement reflects a trend of companies seeking growth through mergers and acquisitions, as well as the use of equity incentive plans to attract and retain talent in competitive industries.

Comparison to Industry Standards

• Reverse stock splits are often used by companies with low share prices to improve their attractiveness to institutional investors, similar to actions taken by other small-cap companies seeking to meet listing requirements.
• Equity incentive plans are a standard practice in the corporate world, with companies like Amazon and Google using stock-based compensation to align employee interests with shareholder value.
• The merger agreement structure, where former members of the acquired company receive a majority ownership stake, is similar to deals seen in the pharmaceutical and healthcare sectors, such as the acquisition of Alere by Abbott Laboratories.

Related Party Transactions

• Pinata is an affiliate of CWR 1, LLC, the Company's majority shareholder, through common ownership.

Stakeholder Impact

• Shareholders will be affected by the name change, potential reverse stock split, and the merger with Polomar Specialty Pharmacy, LLC.
• Employees may benefit from the 2024 Equity and Incentive Compensation Plan.
• Customers and suppliers may see changes as the company transitions to Polomar Health Services, Inc.

Next Steps

• File the Certificate of Amendment with the Secretary of State of the State of Nevada to effect the Amendments.
• Notify FINRA of the Name Change and Reverse Stock Split by filing the requisite documents no later than ten (10) days prior to the anticipated record date of such Actions.
• Consummate the Merger with Polomar Specialty Pharmacy, LLC.

Key Dates

Keywords

merger, reverse stock split, name change, incentive plan, Polomar Health Services, Trustfeed Corp, equity, stock, preferred stock, authorized shares